Unique ID issued by UMIN | UMIN000021514 |
---|---|
Receipt number | R000024808 |
Scientific Title | PRECIOUS trial |
Date of disclosure of the study information | 2016/03/17 |
Last modified on | 2016/03/17 14:22:34 |
PRECIOUS trial
PRECIOUS trial
PRECIOUS trial
PRECIOUS trial
Japan |
advanced and recurrent breast cancer
Breast surgery |
Malignancy
NO
To elucidate the effecacy and safety of pertubumab for the pateints with breast cancer who has been treasted with pertuzumab before.
Safety
Progression-free survival
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
2
Treatment
Medicine |
pertuzumab 420mg/kg iv every 3 week
trasuzumab 6mg/kg iv every 3 week
other chemotherapy(docetaxel, paclitaxel,nab-packitaxel,vinorerbin)
trasuzumab 6mg/kg iv every 3 week
other chemotherapy(docetaxel, paclitaxel,nab-packitaxel,vinorerbin)
20 | years-old | <= |
Not applicable |
Female
1
2
370
1st name | |
Middle name | |
Last name | ken-ichi Ito |
Shinshu unniversity, department of meddicine
Surgery(2)
matumoto city,adahi 3-1-1
0263-37-2657
kenito@shinshu-u.ac.jp
1st name | |
Middle name | |
Last name | ken-ichi Ito |
Shinshu unniversity, department of medicine
Surgery(2)
matumoto city,adahi 3-1-1
0263-37-2657
kenito@shinshu-u.ac.jp
Aichi cancer center hospital
Chugai Pharmaceutical Co
Profit organization
NO
2016 | Year | 03 | Month | 17 | Day |
Unpublished
Open public recruiting
2016 | Year | 03 | Month | 17 | Day |
2016 | Year | 03 | Month | 17 | Day |
2016 | Year | 03 | Month | 17 | Day |
2016 | Year | 03 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024808